Jiangsu Nanfang Medical (603880) — Tangible Net Worth Ratio
Jiangsu Nanfang Medical (603880) has a Tangible Net Worth Ratio of 77.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥40.39 Million) from net assets (CN¥176.20 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 603880 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Jiangsu Nanfang Medical Tangible Net Worth Ratio (2012–2025)
This chart shows how Jiangsu Nanfang Medical's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 77.1%, reflecting net assets of CN¥176.20 Million with intangible assets of CN¥40.39 Million CNY. See operational self-sufficiency of Jiangsu Nanfang Medical to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Jiangsu Nanfang Medical (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Jiangsu Nanfang Medical from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of Jiangsu Nanfang Medical.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 77.5% | CN¥181.17 Million | CN¥40.78 Million | CN¥927.94 Million | ▼ -7.6 pp |
| 2024 | 85.1% | CN¥284.41 Million | CN¥42.33 Million | CN¥1.06 Billion | ▼ -6.5 pp |
| 2023 | 91.6% | CN¥474.22 Million | CN¥39.64 Million | CN¥1.28 Billion | ▼ -1.9 pp |
| 2022 | 93.5% | CN¥621.48 Million | CN¥40.37 Million | CN¥1.46 Billion | ▼ -1.0 pp |
| 2021 | 94.5% | CN¥654.90 Million | CN¥36.18 Million | CN¥1.24 Billion | ▼ -0.3 pp |
| 2020 | 94.8% | CN¥700.80 Million | CN¥36.71 Million | CN¥1.07 Billion | ▼ -0.4 pp |
| 2019 | 95.2% | CN¥567.52 Million | CN¥27.39 Million | CN¥869.60 Million | ▲ +0.2 pp |
| 2018 | 95.0% | CN¥560.04 Million | CN¥28.09 Million | CN¥845.81 Million | ▲ +4.5 pp |
| 2017 | 90.5% | CN¥537.57 Million | CN¥51.07 Million | CN¥822.96 Million | ▲ +10.8 pp |
| 2016 | 79.7% | CN¥256.69 Million | CN¥52.17 Million | CN¥516.55 Million | ▲ +0.4 pp |
| 2015 | 79.3% | CN¥222.51 Million | CN¥46.08 Million | CN¥473.37 Million | ▼ -5.6 pp |
| 2014 | 84.9% | CN¥210.90 Million | CN¥31.94 Million | CN¥437.01 Million | ▼ -10.2 pp |
| 2013 | 95.0% | CN¥168.57 Million | CN¥8.40 Million | CN¥373.35 Million | ▲ +2.1 pp |
| 2012 | 92.9% | CN¥121.38 Million | CN¥8.61 Million | CN¥379.79 Million | — |